These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9089954)

  • 1. Noncytolytic CD8 T cell-mediated suppression of HIV replication.
    Greenberg ML; Lacey SF; Chen CH; Bolognesi DP; Weinhold KJ
    Springer Semin Immunopathol; 1997; 18(3):355-69. PubMed ID: 9089954
    [No Abstract]   [Full Text] [Related]  

  • 2. Noncytolytic HIV immunity.
    Slifka MK
    Trends Microbiol; 1999 Apr; 7(4):143. PubMed ID: 10219049
    [No Abstract]   [Full Text] [Related]  

  • 3. CD8 T cells in HIV infection: mechanisms of immunity.
    Yang OO
    Hosp Pract (1995); 1998 Nov; 33(11):105-8, 111-2, 115-7 passim. PubMed ID: 9826961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication.
    Yang OO; Walker BD
    Adv Immunol; 1997; 66():273-311. PubMed ID: 9328644
    [No Abstract]   [Full Text] [Related]  

  • 5. Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects.
    Rubbert A; Weissman D; Combadiere C; Pettrone KA; Daucher JA; Murphy PM; Fauci AS
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):63-9. PubMed ID: 8989428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines.
    Geiben-Lynn R; Kursar M; Brown NV; Kerr EL; Luster AD; Walker BD
    J Virol; 2001 Sep; 75(17):8306-16. PubMed ID: 11483776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals.
    Hsueh FW; Walker CM; Blackbourn DJ; Levy JA
    Cell Immunol; 1994 Dec; 159(2):271-9. PubMed ID: 7994759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of HIV replication by antiretroviral therapy reduces TIM-3 expression on HIV-specific CD8(+) T cells.
    Kassu A; Marcus RA; D'Souza MB; Kelly-McKnight EA; Palmer BE
    AIDS Res Hum Retroviruses; 2011 Jan; 27(1):1-3. PubMed ID: 20860535
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of CD8
    McBrien JB; Kumar NA; Silvestri G
    Eur J Immunol; 2018 Jun; 48(6):898-914. PubMed ID: 29427516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-specific CD8+ T-cell immune responses and viral replication.
    Buseyne F; Rivière Y
    AIDS; 1993 Nov; 7 Suppl 2():S81-5. PubMed ID: 7909230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells.
    Levy JA; Mackewicz CE; Barker E
    Immunol Today; 1996 May; 17(5):217-24. PubMed ID: 8991383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
    Mollet L; Li TS; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
    J Immunol; 2000 Aug; 165(3):1692-704. PubMed ID: 10903781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions.
    Phillips S; Chokshi S; Riva A; Evans A; Williams R; Naoumov NV
    J Immunol; 2010 Jan; 184(1):287-95. PubMed ID: 19949099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV entry and tropism. When one receptor is not enough.
    Berger EA
    Adv Exp Med Biol; 1998; 452():151-7. PubMed ID: 9889968
    [No Abstract]   [Full Text] [Related]  

  • 16. Elite suppression of HIV-1 replication.
    Blankson JN; Siliciano RF
    Immunity; 2008 Dec; 29(6):845-7. PubMed ID: 19100698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD8+ cell non-cytolytic anti-HIV activity mediated by a novel cytokine.
    Blackbourn DJ; Mackewicz C; Barker E; Levy JA
    Res Immunol; 1994; 145(8-9):653-8; discussion 658-9. PubMed ID: 7754216
    [No Abstract]   [Full Text] [Related]  

  • 18. The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8+ T cell suppression of syncytia-inducing strains of HIV-1.
    Lacey SF; McDanal CB; Horuk R; Greenberg ML
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9842-7. PubMed ID: 9275213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV. Escape artist par excellence.
    Cohen J
    Science; 2003 Mar; 299(5612):1505-8. PubMed ID: 12624245
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemoattractant factors and the control of human immunodeficiency virus replication.
    Baier M; Bannert N; Werner A; Adler HS; Otteken A; Beer B; Norley S; Kurth R
    Pathobiology; 1998; 66(3-4):128-30. PubMed ID: 9693312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.